FlexiLingo
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E. Johnson, MD, MS, MBA, of the University of Chicago joins JAMA Senior Editor Philip Greenland, MD, to discuss the ACC/AHA guideline on management of dyslipidemia. Related Content: Dyslipidemia Evaluation and Management Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy
这一集暂时还没有文字稿
你仍然可以在播放器中收听。有文字稿的节目，点任意单词就能看到释义。